SLN – silence therapeutics plc - american depository share (US:NASDAQ)
Stock Stats
News
New Amsterdam sees success in Phase III cardiovascular disease trial [Yahoo! Finance]
SLN Stock Down Despite Cholesterol Drug Lowering Lipoprotein Levels [Yahoo! Finance]
Silence Therapeutics plc (NASDAQ: SLN) had its "outperform" rating re-affirmed by analysts at William Blair.
Silence Therapeutics Presents Late-Breaking Phase 2 Zerlasiran Data at 2024 American Heart Association (AHA) Annual Meeting [Yahoo! Finance]
Silence Therapeutics Presents Late-Breaking Phase 2 Zerlasiran Data at 2024 American Heart Association (AHA) Annual Meeting
Form 6-K Silence Therapeutics For: Nov 18
Form SC 13G/A Silence Therapeutics Filed by: Lombard Odier Asset Management (USA) Corp
Form SC 13G/A Silence Therapeutics Filed by: Deep Track Capital, LP
Form 6-K Silence Therapeutics For: Sep 30
Form SC 13G/A Silence Therapeutics Filed by: Invus Global Management, LLC
Top News Gainers
Top News Decliners
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.